Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
885
mi
from 43215
McKinney, TX
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
885
mi
from 43215
McKinney, TX
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1009
mi
from 43215
Temple, TX
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1009
mi
from 43215
Temple, TX
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
590
mi
from 43215
Burlington, VT
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
590
mi
from 43215
Burlington, VT
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
329
mi
from 43215
Alexandria, VA
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
329
mi
from 43215
Alexandria, VA
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
428
mi
from 43215
Chesapeake, VA
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
428
mi
from 43215
Chesapeake, VA
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
316
mi
from 43215
Fairfax, VA
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
316
mi
from 43215
Fairfax, VA
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
316
mi
from 43215
Fairfax, VA
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
316
mi
from 43215
Fairfax, VA
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
413
mi
from 43215
Hampton, VA
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
413
mi
from 43215
Hampton, VA
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
305
mi
from 43215
Manassas, VA
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
305
mi
from 43215
Manassas, VA
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
345
mi
from 43215
Mechanicsville, VA
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
345
mi
from 43215
Mechanicsville, VA
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
422
mi
from 43215
Norfolk, VA
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
422
mi
from 43215
Norfolk, VA
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
341
mi
from 43215
Richmond, VA
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
341
mi
from 43215
Richmond, VA
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
341
mi
from 43215
Richmond, VA
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
341
mi
from 43215
Richmond, VA
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
341
mi
from 43215
Richmond, VA
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
341
mi
from 43215
Richmond, VA
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2023
mi
from 43215
Silverdale, WA
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2023
mi
from 43215
Silverdale, WA
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
210
mi
from 43215
Bluefield, WV
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
210
mi
from 43215
Bluefield, WV
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
335
mi
from 43215
Milwaukee, WI
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
335
mi
from 43215
Milwaukee, WI
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
1810
mi
from 43215
Caguas,
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
1810
mi
from 43215
Caguas,
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
331
mi
from 43215
Oxon Hill, MD
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
331
mi
from 43215
Oxon Hill, MD
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
414
mi
from 43215
Saint Peters, MO
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
414
mi
from 43215
Saint Peters, MO
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1282
mi
from 43215
Edinburg, TX
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1282
mi
from 43215
Edinburg, TX
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
328
mi
from 43215
Washington,
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
482
mi
from 43215
Bronx, NY
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
482
mi
from 43215
Bronx, NY
Click here to add this to my saved trials
Role of Nox2 in CNI-induced Renal Fibrosis
The Role of Nox2 in CNI-Induced Renal Fibrosis
Status: Enrolling
Updated:  12/31/1969
Wisconsin Institute for Medical Research (WIMR)
392
mi
from 43215
Madison, WI
Role of Nox2 in CNI-induced Renal Fibrosis
The Role of Nox2 in CNI-Induced Renal Fibrosis
Status: Enrolling
Updated: 12/31/1969
Wisconsin Institute for Medical Research (WIMR)
392
mi
from 43215
Madison, WI
Click here to add this to my saved trials
Role of Nox2 in CNI-induced Renal Fibrosis
The Role of Nox2 in CNI-Induced Renal Fibrosis
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin Hospital and Clinics
394
mi
from 43215
Madison, WI
Role of Nox2 in CNI-induced Renal Fibrosis
The Role of Nox2 in CNI-Induced Renal Fibrosis
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin Hospital and Clinics
394
mi
from 43215
Madison, WI
Click here to add this to my saved trials
Genetic Predictors of Renal Dysfunction Following Heart Transplantation
Pharmacogenomics of Calcineurin Inhibitor Nephrotoxicity in Cardiac Transplantation
Status: Enrolling
Updated:  12/31/1969
University of Colorado Anschutz Medical Campus
1154
mi
from 43215
Aurora, CO
Genetic Predictors of Renal Dysfunction Following Heart Transplantation
Pharmacogenomics of Calcineurin Inhibitor Nephrotoxicity in Cardiac Transplantation
Status: Enrolling
Updated: 12/31/1969
University of Colorado Anschutz Medical Campus
1154
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
Outcome of BCF Access in Hemodialysis Patients
A Clinical and Computational Study to Improve Brachiocephalic Fistula (BCF) Outcomes
Status: Enrolling
Updated:  12/31/1969
University of Chicago Medical Center
270
mi
from 43215
Chicago, IL
Outcome of BCF Access in Hemodialysis Patients
A Clinical and Computational Study to Improve Brachiocephalic Fistula (BCF) Outcomes
Status: Enrolling
Updated: 12/31/1969
University of Chicago Medical Center
270
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Adipose Tissue Function After Pancreas Transplantation
A Pilot Study to Identify the Differences in Adipose Tissue Function After Restoring Normal Glycemic Control Following Pancreas Transplantation
Status: Enrolling
Updated:  12/31/1969
The University of Texas Medical Branch (UTMB)
994
mi
from 43215
Galveston, TX
Adipose Tissue Function After Pancreas Transplantation
A Pilot Study to Identify the Differences in Adipose Tissue Function After Restoring Normal Glycemic Control Following Pancreas Transplantation
Status: Enrolling
Updated: 12/31/1969
The University of Texas Medical Branch (UTMB)
994
mi
from 43215
Galveston, TX
Click here to add this to my saved trials
Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease
The Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease (in the Grant Entitled: Endothelial Dysfunction in the Pathogenesis of Sickle Cell Nephropathy)
Status: Enrolling
Updated:  12/31/1969
UNC School of Medicine Clinical&Translational Research Ctr
328
mi
from 43215
Chapel Hill, NC
Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease
The Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease (in the Grant Entitled: Endothelial Dysfunction in the Pathogenesis of Sickle Cell Nephropathy)
Status: Enrolling
Updated: 12/31/1969
UNC School of Medicine Clinical&Translational Research Ctr
328
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
410
mi
from 43215
Huntsville, AL
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
410
mi
from 43215
Huntsville, AL
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1658
mi
from 43215
Tempe, AZ
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1658
mi
from 43215
Tempe, AZ
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1965
mi
from 43215
Alhambra, CA
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1965
mi
from 43215
Alhambra, CA
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1949
mi
from 43215
Chula Vista, CA
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1949
mi
from 43215
Chula Vista, CA
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1980
mi
from 43215
Inglewood, CA
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1980
mi
from 43215
Inglewood, CA
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1942
mi
from 43215
La Mesa, CA
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1942
mi
from 43215
La Mesa, CA
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1967
mi
from 43215
La Palma, CA
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1967
mi
from 43215
La Palma, CA
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1982
mi
from 43215
Northridge, CA
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1982
mi
from 43215
Northridge, CA
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1972
mi
from 43215
Paramount, CA
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1972
mi
from 43215
Paramount, CA
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1935
mi
from 43215
Riverside, CA
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1935
mi
from 43215
Riverside, CA
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2028
mi
from 43215
Roseville, CA
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2028
mi
from 43215
Roseville, CA
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1946
mi
from 43215
San Dimas, CA
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1946
mi
from 43215
San Dimas, CA
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1963
mi
from 43215
Whittier, CA
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1963
mi
from 43215
Whittier, CA
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
989
mi
from 43215
Hialeah, FL
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
989
mi
from 43215
Hialeah, FL
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
993
mi
from 43215
Miami, FL
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
993
mi
from 43215
Miami, FL
Click here to add this to my saved trials
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
993
mi
from 43215
Miami, FL
A Study of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not Receiving Dialysis
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
993
mi
from 43215
Miami, FL
Click here to add this to my saved trials